A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers

Author(s):  
Yue Hu ◽  
Hong Zhang ◽  
Xiaojiao Li ◽  
Jiajia Mai ◽  
Lizhi Yang ◽  
...  
Vaccine ◽  
2012 ◽  
Vol 30 (22) ◽  
pp. 3295-3303 ◽  
Author(s):  
Yan-Ping Li ◽  
Zheng-Lun Liang ◽  
Qiang Gao ◽  
Li-Rong Huang ◽  
Qun-Ying Mao ◽  
...  

Burns ◽  
2019 ◽  
Vol 45 (4) ◽  
pp. 914-922 ◽  
Author(s):  
Mahnoush Momeni ◽  
Nasrin Fallah ◽  
Amir Bajouri ◽  
Tooran Bagheri ◽  
Zahra Orouji ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document